On 27 February 2017, orphan designation (EU/3/17/1842) was granted by the European Commission to EUDRAC Limited, United Kingdom, for recombinant human club cell 10 KDa protein for the treatment of bronchiolitis obliterans syndrome.
The sponsorship was transferred to EUDRAC GmbH, Germany, in April 2019.
Recombinant human club cell 10 KDa protein
|Disease / condition||
Treatment of bronchiolitis obliterans syndrome
|Date of decision||
|Orphan decision number||
Review of designation
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
- European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
- Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe;